IamFluidics

Executive Summary

IamFluidics is a Dutch biotech company founded in 2019 that specializes in advanced microencapsulation solutions for life sciences and biopharma applications. Its proprietary IN-AIR MICROFLUIDICS™ platform enables the production of highly uniform microparticles and microcapsules with precise control over size, composition, and release profiles. The company targets key applications such as controlled-release injectables, oral delivery of sensitive bioactives, and dissolvable microcarriers for cell therapy manufacturing. By addressing critical challenges in drug delivery and cell culture scalability, IamFluidics positions itself as an enabler for next-generation therapeutics. Though still in early stages with no disclosed funding, the company's technology has potential to differentiate in a competitive landscape dominated by traditional encapsulation methods.

Upcoming Catalysts (preview)

• Q4 2026First commercial partnership or licensing deal with a pharma partner40% success
• Q1 2027Series A funding round to scale operations and validate platform50% success
• Q2 2027Entry into the dissolvable microcarrier market with a lead application in cell therapy35% success